nifedipine (nif) a 1, 4-dihydropyridine calcium channel antagonist, undergoes photodegradation to nitroso analogues of dehydronifedipine (ndnif) when exposed to sunlight. photodegradation products of nif have no clinical activity, so different formulations of nif must remain unchanged. if nif preparations become unstable in exposure to light, they could cause therapeutic failure. the present st...

Nifedipine (NIF) a 1, 4-dihydropyridine calcium channel antagonist, undergoes photodegradation to nitroso analogues of dehydronifedipine (NDNIF) when exposed to sunlight. Photodegradation products of NIF have no clinical activity, so different formulations of NIF must remain unchanged. If NIF preparations become unstable in exposure to light, they could cause therapeutic failure. The present st...

results the results show the artificial lighting obtained by difference methods of the overall lighting from natural lighting in closed blinds mode equal to 266 lux and night lighting 283.5 lux that they have no significant differences with each other (p = 0.269). as well as the illumination intensity obtained from a standard grid method is 283.5 lux and illumination intensity based on luminair...

Nifedipine (NIF) a 1, 4-dihydropyridine calcium channel antagonist, undergoes photodegradation to nitroso analogues of dehydronifedipine (NDNIF) when exposed to sunlight. Photodegradation products of NIF have no clinical activity, so different formulations of NIF must remain unchanged. If NIF preparations become unstable in exposure to light, they could cause therapeutic failure. The present st...